Zum Hauptinhalt springen
Nicht aus der Schweiz? Besuchen Sie lehmanns.de
Food & Drug Administration Safety & Innovation Act -

Food & Drug Administration Safety & Innovation Act

Provisions & Analyses of User Fees

James C Perry (Herausgeber)

Buch | Hardcover
157 Seiten
2014
Nova Science Publishers Inc (Verlag)
978-1-62948-774-8 (ISBN)
CHF 289,95 inkl. MwSt
  • Versand in 10-20 Tagen
  • Versandkostenfrei
  • Auch auf Rechnung
  • Artikel merken
The Food and Drug Administration Safety and Innovation Act (FDASIA), amends the Federal Food, Drug, and Cosmetic Act (FFDCA) to expand the authority of the Food and Drug Administration (FDA) in performing its human drug, biological product, and medical device responsibilities. Frequently referred to as the user fee reauthorisation act, FDASIA does include four titles relating to user fees. This book focuses on these acts, as well as the prescription drug user fee act, the FDA medical device user fee program and discusses the proposed FDA user fee acts generic drug user fee amendments.

Preface; The Food & Drug Administration Safety & Innovation Act (FDASIA, P.L. 112-144); Prescription Drug User Fee Act (PDUFA): 2012 Reauthorization as PDUFA V; The FDA Medical Device User Fee Program; Proposed FDA User Fee Acts: Generic Drug User Fee Amendments of 2012 (GDUFA) & Biosimilar User Fee Act of 2012 (BSUFA); Index.

Erscheint lt. Verlag 1.3.2014
Verlagsort New York
Sprache englisch
Maße 155 x 230 mm
Gewicht 392 g
Themenwelt Technik Lebensmitteltechnologie
ISBN-10 1-62948-774-0 / 1629487740
ISBN-13 978-1-62948-774-8 / 9781629487748
Zustand Neuware
Informationen gemäß Produktsicherheitsverordnung (GPSR)
Haben Sie eine Frage zum Produkt?
Mehr entdecken
aus dem Bereich
Technologie, Chemie, Mikrobiologie, Analytik, Bedeutung, Recht

von Franz-Michael Rouwen; Tilo Hühn

Buch | Hardcover (2023)
Verlag Eugen Ulmer
CHF 169,00
A Laboratory Manual

von Dennis D. Miller; C. K. Yeung

Buch | Softcover (2022)
John Wiley & Sons Inc (Verlag)
CHF 103,00